Stay updated on Cabozantinib and Durvalumab Immuno-oncology Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    No significant additions or deletions were observed on the ARCADIA study page. The published study details remain unchanged.
    Difference
    0.4%
    Check dated 2025-10-27T21:05:07.000Z thumbnail image
  3. Check
    31 days ago
    Change Detected
    Summary
    Major update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T08:10:31.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Page revision updated to v3.1.0 with new contact emails added; v3.0.2 removed. No clear changes to pricing or stock detected.
    Difference
    0.1%
    Check dated 2025-09-29T04:37:31.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1, and the 'Back to Top' link has been removed.
    Difference
    0.1%
    Check dated 2025-09-14T22:12:22.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-07T19:21:16.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location to Milan, Italy, and has added specific drug names, including cabozantinib and durvalumab, while removing several related medical topics and previous location details.
    Difference
    1%
    Check dated 2025-08-31T12:26:30.000Z thumbnail image

Stay in the know with updates to Cabozantinib and Durvalumab Immuno-oncology Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page.